Brief: Hofseth Biocare Q3 EBITDA Loss Widens To NOK 14.7 Mln

Hofseth Biocare ASA

02/11/2018 07:19

Nov 2 (Reuters) - Hofseth Biocare ASA  HOFBC.OL :
    * OPERATING REVENUES OF NOK 16.9M (27.9M) IN Q3 OF 2018
    * SALES REVENUES FOR FIRST NINE MONTHS OF 2018 AMOUNTED TO NOK 46.3M (39.8M)
    * OPERATIONAL PROFIT (EBITDA) FOR Q3 2018 WAS NEGATIVE NOK 14.7M (6.3M)
    * HOFSETH BIOCARE - "CONTINUED PRODUCT DEVELOPMENT ON FINISHED PRODUCTS IS EXPECTED TO HAVE
POSITIVE EFFECTS ON OUR RESULTS IN 2018 AND ONWARDS"

Source text for Eikon:  ID:nGNE6ZMCf0 
Further company coverage:  HOFBC.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))